Drug stocks sag as Amgen climbs on upgrade

Drug stocks sag in early trading Friday while shares of Amgen Inc. rise on an upgrade from J.P. Morgan.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.